BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35311155)

  • 61. Immunohistochemistry analysis reveals lysyl oxidase-like 3 as a novel prognostic marker for primary melanoma.
    Zhang X; Su MW; Cheng Y; Martinka M; Wang G; Huang Y; Li L; Zhou Y
    Melanoma Res; 2021 Apr; 31(2):173-177. PubMed ID: 33625099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer.
    Hu K; Yao L; Xu Z; Yan Y; Li J
    Front Cell Dev Biol; 2022; 10():832354. PubMed ID: 35155439
    [No Abstract]   [Full Text] [Related]  

  • 63. Upregulated expression of LOX is a novel independent prognostic marker of worse outcome in gastric cancer patients after curative surgery.
    Zhang Q; Jin XS; Yang ZY; Wei M; Zhu XC; Wang P; Liu BY; Gu QL
    Oncol Lett; 2013 Mar; 5(3):896-902. PubMed ID: 23425977
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RNF144A-AS1, a TGF-β1- and hypoxia-inducible gene that promotes tumor metastasis and proliferation via targeting the miR-30c-2-3p/LOX axis in gastric cancer.
    Li Z; Shi L; Li X; Wang X; Wang H; Liu Y
    Cell Biosci; 2021 Sep; 11(1):177. PubMed ID: 34583752
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recognition of lysyl oxidase as a potential predictive biomarker for oral squamous cell carcinoma: an immunohistochemical study.
    Bhanu U; Natarajan S; Manaktala N; Boaz K; Joshi R; Deepak S; Kp N; Lewis A
    Minerva Stomatol; 2020 Dec; 69(6):360-369. PubMed ID: 32744444
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.
    Mižíková I; Palumbo F; Tábi T; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
    Physiol Genomics; 2017 Aug; 49(8):416-429. PubMed ID: 28698228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal Neovascularization.
    Van Bergen T; Spangler R; Marshall D; Hollanders K; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5280-9. PubMed ID: 26258612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.
    Wang L; Wei Q; Zhang M; Chen L; Li Z; Zhou C; He M; Wei M; Zhao L
    Int Immunopharmacol; 2020 Oct; 87():106795. PubMed ID: 32707495
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours.
    Setargew YFI; Wyllie K; Grant RD; Chitty JL; Cox TR
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase.
    Jeong C; Kim Y
    Int J Mol Med; 2017 Mar; 39(3):719-724. PubMed ID: 28112368
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A new role for LOX and LOXL2 proteins in transcription regulation.
    Iturbide A; García de Herreros A; Peiró S
    FEBS J; 2015 May; 282(9):1768-73. PubMed ID: 25103872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes.
    Ribeiro AL; Kaid C; Silva PBG; Cortez BA; Okamoto OK
    Stem Cells Int; 2017; 2017():4972078. PubMed ID: 28553358
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of LOX and LOXL2 in scar formation after glaucoma surgery.
    Van Bergen T; Marshall D; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5788-96. PubMed ID: 23821193
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Common polymorphisms in human lysyl oxidase genes are not associated with the adolescent idiopathic scoliosis phenotype.
    McGregor TL; Gurnett CA; Dobbs MB; Wise CA; Morcuende JA; Morgan TM; Menon R; Muglia LJ
    BMC Med Genet; 2011 Jul; 12():92. PubMed ID: 21740577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
    Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y
    Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
    Zhou Q; Zhou J; Fan J
    Front Oncol; 2021; 11():638803. PubMed ID: 34094918
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma.
    Ma Y; Qiu M; Guo H; Chen H; Li J; Li X; Yang F
    Front Oncol; 2021; 11():633420. PubMed ID: 33747955
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
    Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
    Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LOXL2 in cancer: regulation, downstream effectors and novel roles.
    Wen B; Xu LY; Li EM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.